When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 10 Hits
  • Search Condition : Filter (MeSH = Prostatic Neoplasms / drug therapy*)
Species Resource
Human and Animal Cells Eph receptor A10 has a potential as a target for a prostate cancer therapy.
Human and Animal Cells ST2 (RCB0224) MLC-6 (RCB1536) Indirect antitumor effects of bisphosphonates on prostatic LNCaP cells co-cultured with bone cells.
Mice ICR;129P2-Nfe2l2<tm1Mym>/MymRbrc Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention.
Human and Animal Cells LNCap.FGC(RCB2144) Docetaxel induces Bcl-2- and pro-apoptotic caspase-independent death of human prostate cancer DU145 cells.
Human and Animal Cells PC-3(RCB2145) Class IIb HDAC Inhibition Enhances the Inhibitory Effect of Am80, a Synthetic Retinoid, in Prostate Cancer.
Human and Animal Cells DU145(RCB2143) Lapatinib-resistant cancer cells possessing epithelial cancer stem cell properties develop sensitivity during sphere formation by activation of the ErbB/AKT/cyclin D2 pathway.
Human and Animal Cells LNCap.FGC(RCB2144) Hollow boron nitride nanospheres as boron reservoir for prostate cancer treatment.
Human and Animal Cells DU145(RCB2143) Systematic Trial for Evaluating Docetaxel in a Human Prostate Cancer Cell DU145 Xenograft Model.
Human and Animal Cells Novel HER2 selective tyrosine kinase inhibitor, TAK-165, inhibits bladder, kidney and androgen-independent prostate cancer in vitro and in vivo.
Human and Animal Cells p-Dodecylaminophenol derived from the synthetic retinoid, fenretinide: antitumor efficacy in vitro and in vivo against human prostate cancer and mechanism of action.